Feasibility of telerehabilitation during hematopoietic stem cell therapy of hemato-oncologic cancer patients: a pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006487

Enrollment

Registered

2021-08-23

Start date

2021-09-13

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(rehabilitation exercise) : - Treatment is carried out 3-4 times a week for 3 weeks depending on the patient's condition. In some cases, exercise is difficult due to cancer and bone marrow trans

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients aged between 20 and under 75 who have been diagnosed with hemato-oncologic cancer and are planning a stem cell transplantation.

Exclusion criteria

Exclusion criteria: 1) A musculoskeletal disease or neurological disease that makes it difficult to exercise 2) In case of treatment with a history of cardiovascular disease 3) When it is difficult to perform non-face-to-face rehabilitation exercise treatment due to visual and auditory abnormalities 4) Taking medication for a mental illness such as depression or insomnia 5) Difficult to participate in the exercise program for other reasons

Design outcomes

Primary

Measure	Time frame
European Orgaization for Research and Treatment of Cancer (EORTC)-Quality of life. Questionnaire 30 (QLQ-C30)	—

Secondary

Measure	Time frame
Beck depression inventory;hand grip strength;6 minute-walk test;Berg balance test;Bioimpedance analysis	—

Countries

Korea, Republic of

Contacts

Public ContactChung Reen Kim

Ulsan Univeristy Hospital

crikim@uuh.ulsan.kr+82-52-250-8730

Outcome results